創升控股(02680.HK)中期收益總額增長44.5%至4332萬港元
格隆匯10月28日丨創升控股(02680.HK)發佈中期業績,截至2019年8月31日止六個月,公司實現收益總額4332萬港元,同比增長44.5%;期內虧損232.4萬港元,上年同期盈利87.2萬港元;基本每股虧損0.58港仙;不派息。
公告表示,報告期內,集團收益總額增長主要由於配售及包銷服務、證券交易及經紀服務以及證券融資服務業務有所改善。然而,集團於該期間產生虧損230萬港元,而於2018年同期盈利87.2萬港元,減少約366.5%,主要由於公司股份於2018年上市後員工成本以及行政及經營開支增加所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.